US$ 28.51
glutathione treatment and parkinson& 39 Parkinson's Disease JCI - Midbrain dopamine oxidation
Description
PLoS One 9, e105186

We need novel therapies that are not only potent in terms of their capability of normalising glucose, but also have the ability to slow the progression of the disease
/assets/images/provider/photos/2737000.jpeg)
doi: 10.3390/molecules24010083 125 GuoDChenFWheelerJWinderJSelmanSPetersonMet al

M.ZengE.PasinettiG

Crit Rev Toxicol 31: 55138, 2001 [DOI] [PubMed] [Google Scholar] 2.Hinson JA, Roberts DW, James LP: Mechanisms of acetaminophen-induced liver necrosis
